Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC

Arthur, 2000, The glutathione peroxidases, Cell. Mol. Life Sci. CMLS, 57, 1825, 10.1007/PL00000664 Ayton, 2015, Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor protein, J. Neurosci., 35, 3591, 10.1523/JNEUROSCI.3439-14.2015 Bellinger, 2011, Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson's brain, Mol. Neurodegener., 6, 8, 10.1186/1750-1326-6-8 Blackinton, 2009, Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease, Neurosci. Lett., 452, 8, 10.1016/j.neulet.2008.12.053 Cavaliere, 2010, An organotypic culture model to study nigro-striatal degeneration, J. Neurosci. Methods, 188, 205, 10.1016/j.jneumeth.2010.02.008 Chen, 2009, Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades, Eur. J. Neurosci., 29, 287, 10.1111/j.1460-9568.2008.06590.x Devos, 2014, Targeting chelatable iron as a therapeutic modality in Parkinson's disease, Antioxid. Redox Signal., 21, 195, 10.1089/ars.2013.5593 Dixon, 2012, Ferroptosis: an iron-dependent form of nonapoptotic cell death, Cell, 149, 1060, 10.1016/j.cell.2012.03.042 Dolma, 2003, Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells, Cancer Cell, 3, 285, 10.1016/S1535-6108(03)00050-3 Fenton, 1894, LXXIII.—oxidation of tartaric acid in presence of iron, J. Chem. Soc. Trans., 65, 899, 10.1039/CT8946500899 Friedmann Angeli, 2014, Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice, Nat. Cell Biol., 16, 1180, 10.1038/ncb3064 Hare, 2015, Is early-life iron exposure critical in neurodegeneration?, Nat. Rev. Neurol., 11, 536, 10.1038/nrneurol.2015.100 Hemendinger, 2008, Huperzine A provides neuroprotection against several cell death inducers using in vitro model systems of motor neuron cell death, Neurotox. Res., 13, 49, 10.1007/BF03033367 Kanai, 2003, Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity, J. Toxicol. Sci., 28, 1, 10.2131/jts.28.1 Kang, 2014, Cellular protection using Flt3 and PI3Kα inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity, Nat. Commun., 5, 3672, 10.1038/ncomms4672 Linert, 2000, Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's disease, J. Inorg. Biochem., 79, 319, 10.1016/S0162-0134(99)00238-X Lo, 2008, The xc-cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance, Br. J. Cancer, 99, 464, 10.1038/sj.bjc.6604485 Martel, 2014, VDAC phosphorylation, a lipid sensor influencing the cell fate, Mitochondrion, 19, 69, 10.1016/j.mito.2014.07.009 Napolitano, 2011, Oxidation chemistry of catecholamines and neuronal degeneration: an update, Curr. Med. Chem., 18, 1832, 10.2174/092986711795496863 Robert, 2012, The caspase 6 derived N-terminal fragment of DJ-1 promotes apoptosis via increased ROS production, Cell Death Differ., 19, 1769, 10.1038/cdd.2012.55 Schildknecht, 2013, Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases, ALTEX, 30, 427, 10.14573/altex.2013.4.427 Schmidt, 2000, Ras-independent activation of the Raf/MEK/ERK pathway upon calcium-induced differentiation of keratinocytes, J. Biol. Chem., 275, 41011, 10.1074/jbc.M003716200 Skouta, 2014, Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models, J. Am. Chem. Soc., 136, 4551, 10.1021/ja411006a Sun, 2012, Voltage-dependent anion channels (VDACs) recruit Parkin to defective mitochondria to promote mitochondrial autophagy, J. Biol. Chem., 287, 40652, 10.1074/jbc.M112.419721 Triplett, 2015, Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease, J. Neurochem., 133, 750, 10.1111/jnc.13039 Uversky, 2001, Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure, J. Biol. Chem., 276, 44284, 10.1074/jbc.M105343200 Vaughn, 2008, Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c, Nat. Cell Biol., 10, 1477, 10.1038/ncb1807 Weinreb, 2013, Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators, Free Radic. Biol. Med., 62, 52, 10.1016/j.freeradbiomed.2013.01.017 Wen-Sheng, 2006, Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2, Cancer Lett., 239, 27, 10.1016/j.canlet.2005.07.034 Wersinger, 2004, Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation, Mol. Cell. Neurosci., 25, 124, 10.1016/j.mcn.2003.10.002 Yagoda, 2007, RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels, Nature, 447, 864, 10.1038/nature05859 Yang, 2014, Regulation of ferroptotic cancer cell death by GPX4, Cell, 156, 317, 10.1016/j.cell.2013.12.010 Yoo, 2012, Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain, Free Radic. Biol. Med., 52, 1820, 10.1016/j.freeradbiomed.2012.02.043 Youdim, 2004, A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease, Neurology, 63, S32, 10.1212/WNL.63.7_suppl_2.S32 Zeevalk, 2008, Glutathione and Parkinson's disease: is this the elephant in the room?, Biomed. Pharmacother., 62, 236, 10.1016/j.biopha.2008.01.017 Zhang, 2014, PKC in developmental hypothyroid rat brain, Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol., 35, 1161